Trilliome pioneers precision bioactives for healthy aging. Combining advanced human gut and in-silico models, we identify plant compounds that selectively restore keystone microbes. Our science-backed B2B ingredients target brain and immune health, defining a new frontier in biotech.
Some insights
Our strengths lie in R&D and commercial expertise spanning inflammation, microbiome, oncology, aging-related and metabolic diseases across modalities. We are now expanding our core team to drive industrial scale-up and global market entry.
